fda warning about semaglutide The U.S. Food and Drug Administration (FDA) has issued a to Novo Nordisk over its alleged failure to report adverse side effects, including death, in patients who took its GLP-1 medications FDA Approves Semaglutide to Prevent

Side effects and safety considerations for semaglutide with b12 Vitamin b12 has remarkably low toxicity

Same thing with pancreatitis history, though thats pretty rare

For patients using specific dose targets, understanding conversions like 10 units in milligrams , 20 units in milligrams , or 20 units in milliliters helps ensure accurate dosing

I highly recommend Dr

If you want to get an accurate kidney function assessment, stop creatine for 3-5 days before the blood draw, or ask for a cystatin C test, which is not affected by creatine supplementation

May your stomach stay comfortable, your meals stay enjoyable, and your GLP-1 journey stay on track.